Ashwini L. Chand

2.3k citations
41 papers · 1.6k indexed · 1 hit paper · h-index 22

Ashwini L. Chand

41 papers receiving 1.6k citations

Hit Papers

Therapeutically exploiting STAT3 activity in cancer — usi...3822018202620202023100200300

Peers

Ashwini L. Chand
Comparison fields: 5 of 87
  • Reproductive Medicine 219
  • Oncology 566
  • Cancer Research 242
  • Immunology 329
  • Genetics 314
Replace Oliver Treeck with:
Oliver Treeck Germany
Benjamin S. Leung United States
Andrzej Semczuk Poland
Judit Pallarés Spain
Tsunekazu Kita Japan
Ruben R. Gonzalez‐Perez United States
Wenru Tang China
Michihiro Tanikawa Japan
Hans-Juergen Schulten Saudi Arabia
Ashwini L. Chand relative to Oliver Treeck Germany Oliver Treeck's profile →
Citations per field
00.5×1.5×1.8×
Oliver Treeck · 1×
Citations per year

Countries citing papers authored by Ashwini L. Chand

Since Specialization
Citations

This map shows the geographic impact of Ashwini L. Chand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwini L. Chand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwini L. Chand more than expected).

Fields of papers citing papers by Ashwini L. Chand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwini L. Chand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwini L. Chand. The network helps show where Ashwini L. Chand may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ashwini L. Chand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ashwini L. Chand Line = papers co-authored together Ashwini L. Chand links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20245
2 20243
3 202263
4 202119
5 202118
6 202129
7 202024
8 201936
9 201986
10
Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road mapbreakdown →
2018382
11 20172
12 201310
13 201317
14 201250
15 201113
16 20117
17 201074
18 200926
19 200732
20 200668

About Ashwini L. Chand

Ashwini L. Chand is a scholar working on Oncology, Reproductive Medicine and Genetics, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Reproductive Biology and Fertility (9 papers), Estrogen and related hormone effects (9 papers), TGF-β signaling in diseases (7 papers), Cytokine Signaling Pathways and Interactions (7 papers), Reproductive System and Pregnancy (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Reproductive Medicine (219 citations), Oncology (566 citations) and Cancer Research (242 citations). Ashwini L. Chand has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Matthias Ernst, Jennifer Huynh, Daniel J. Gough, Andrew N. Shelling, Colin D. Clyne, Craig A. Harrison, Ingrid Winship, Tracy L. Nero, Tracy L. Putoczki and Evan R. Simpson.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026